Cytek Biosciences, Inc. (CTKB): Cash & Equivalents
$90.85M
As of 2025-12-31
$73.85M
As of 2026-06-30
-32.6%
3-year compound annual growth
-11.3%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $90.85M | -8.0% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $98.72M | -41.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $167.30M | -43.6% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $296.60M | -18.7% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $364.62M | +120.7% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $165.23M | n/a | 2022-03-17, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $90.85M | -8.0% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $63.71M | +15.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $29.84M | -47.4% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $8.61M | +109.7% |
| 10x Genomics, Inc. (TXG) | 2024-12-31 | $344.07M | -4.2% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $70.52M | +60.1% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $20.03M | +18.4% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $101.82M | +2.1% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $2.99M | -67.4% |
Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗